SCOSI-M: Preventing Prescription Drug Problems

Not Applicable

Completed

• Conditions: Prescription Drug Problems
• Interventions: Other: Educational Intervention

• Registration Number: NCT02210936
• Lead Sponsor: Brandeis University

Brief Summary

Brandeis University and University of South Carolina (USC) have joined together to develop the South Carolina Opioid Safety Initiative - Military (SCOSI-M), to develop an academic detailing (medical education) intervention for physicians and evaluate its effectiveness in a pilot study. The goal of the intervention is to increase the use of safe prescribing and prescription monitoring practices among primary care physicians. The research team will design and pilot an educational intervention for physicians who treat military personnel, veterans, and their families with prescription opioids. The overall aim of SCOSI-M is to prevent the onset or progression of prescription drug problems among Iraq and Afghanistan veterans, military members, and their families who are at high risk for developing problems if their treatment involves long-term use of an opioid.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-07
• Study First Submitted: 2014-07-10
• Study First Submitted QC: 2014-08-05
• Study First Posted: 2014-08-07
• Primary Completion: 2019-05
• Study Completion: 2019-05
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-08
• Last Update Posted: 2020-07-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 93

Inclusion Criteria

1. a physician within one of the 3 practice environments;
2. typically prescribes Schedule II opioids to 10 or more non-cancer pain patients each month;
3. if community office-based, a substantial number of patients must have TRICARE (e.g., 20%); and d) willing to provide written consent for data collection and release of own SCRIPTS data.

Exclusion Criteria

1. non-physician providers who report data to the SCRIPTS (dentist, veterinarians, nurses),
2. surgeons, pediatricians, or physicians predominately treating pain in cancer or surgical patients, and,
3. not eligible to register as authorized SCRIPTS user.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
PDMP Data	Educational Intervention	-

Primary Outcome Measures

Name	Time	Method
Use of SCRIPTS	Up to 12 months	Primary outcomes, or effectiveness, will be measured first by the use of SCRIPTS when prescribing opioids (e.g., % of new patients the physician queried; % of patients with long-term use the physician queried).

Trial Locations

Locations (1)

Brandeis University; 🇺🇸 Waltham, Massachusetts, United States